Literature DB >> 7739763

Regional alterations of dopamine and its metabolites in rat brain following portacaval anastomosis.

M Bergeron1, M S Swain, T A Reader, R F Butterworth.   

Abstract

Hyperammonemia and changes in brain monoamine metabolism have been proposed to contribute to the pathogenesis of the neuropsychiatric symptoms characteristic of human portal-systemic encephalopathy (PSE) resulting from chronic liver disease. Portacaval anastomosis (PCA) in the rat leads to sustained hyperammonemia and mild encephalopathy. In order to evaluate the role of dopamine (DA) metabolism in PSE, levels of DA and its metabolites were measured by HPLC with electrochemical detection in brain regions of rats with PCA at various stages of encephalopathy precipitated by ammonium acetate administration. Following ammonium acetate administration, rats with PCA rapidly develop severe neurological signs of encephalopathy progressing through loss of righting reflex to coma; sham-operated control animals administered ammonium acetate showed no such neurological deterioration. Concentrations of the DA metabolites DOPAC and HVA as well as [DA metabolites]/[DA] ratios, an indirect measure of DA turnover in brain, were increased in caudate-putamen, in cingulate and pyriform entorhinal cortices as well as in raphe nucleus and locus coeruleus. Increased DA metabolites, however, did not worsen at coma stages of PSE. Increased DA turnover thus appears to relate to early neuropsychiatric and extrapyramidal symptoms of PSE.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7739763     DOI: 10.1007/bf00995156

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  Blood-ammonium levels in liver disease and hepatic coma.

Authors:  E A PHEAR; S SHERLOCK; W H SUMMERSKILL
Journal:  Lancet       Date:  1955-04-23       Impact factor: 79.321

2.  Episodic stupor associated with an Eck fistula in the human with particular reference to the metabolism of ammonia.

Authors:  W V McDERMOTT; R D ADAMS
Journal:  J Clin Invest       Date:  1954-01       Impact factor: 14.808

3.  Experimental hepatic encephalopathy. Changes of the level of wakefulness in the rat with portacaval shunt.

Authors:  C Beaubernard; F Salomon; D Grange; M J Thangapregassam; J Bisbuth
Journal:  Biomedicine       Date:  1977-06

4.  Portacaval shunt in the rat.

Authors:  S H LEE; B FISHER
Journal:  Surgery       Date:  1961-10       Impact factor: 3.982

Review 5.  The current status of the dopamine hypothesis of schizophrenia.

Authors:  A Carlsson
Journal:  Neuropsychopharmacology       Date:  1988-09       Impact factor: 7.853

6.  [Experimental hepathic enchalopathy in rat. Clinical and electrocorticographic study].

Authors:  R Cloche; J D Degos; C H Bismuth; J P Benhamou
Journal:  Rev Fr Etud Clin Biol       Date:  1969-03

7.  Effect of ammonia on brain serotonin metabolism in relation to function in the portacaval shunted rat.

Authors:  M Bergeron; M S Swain; T A Reader; L Grondin; R F Butterworth
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

8.  Portacaval anastomosis: brain and plasma metabolite abnormalities and the effect of nutritional therapy.

Authors:  A M Mans; J F Biebuyck; D W Davis; R A Hawkins
Journal:  J Neurochem       Date:  1984-09       Impact factor: 5.372

Review 9.  Ammonia: key factor in the pathogenesis of hepatic encephalopathy.

Authors:  R F Butterworth; J F Giguère; J Michaud; J Lavoie; G P Layrargues
Journal:  Neurochem Pathol       Date:  1987 Feb-Apr

10.  Aromatic and branched-chain amino acids in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

Authors:  M Bergeron; G P Layrargues; R F Butterworth
Journal:  Metab Brain Dis       Date:  1989-09       Impact factor: 3.584

View more
  2 in total

1.  Portacaval anastomosis results in more widespread alterations of cerebral metabolism in old versus young adult rats: implications for post-shunt encephalopathy.

Authors:  R M Audet; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-03       Impact factor: 3.584

2.  Release of [3H]dopamine from striatal and cerebral cortical slices from rats with thioacetamide-induced hepatic encephalopathy: different responses to stimulation by potassium ions and agonists of ionotropic glutamate receptors.

Authors:  H D Borkowska; S S Oja; P Saransaari; J Albrecht
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.